Equities

Shanghai Titan Scientific Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Shanghai Titan Scientific Co Ltd

Actions
Basic MaterialsChemicals
  • Price (CNY)24.11
  • Today's Change-0.22 / -0.90%
  • Shares traded2.79m
  • 1 Year change+21.28%
  • Beta1.5428
Data delayed at least 15 minutes, as of Feb 13 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
688133:SHH since
announced
Transaction
value
Apollo Scientific LtdDeal completed24 Jul 202524 Jul 2025Deal completed-6.62%7.82m
Data delayed at least 15 minutes, as of Feb 13 2026.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Suli Co Ltd2.73bn119.78m3.82bn1.83k33.791.44--1.400.60550.605513.5514.200.48034.975.651,494,286.002.043.992.956.1917.1219.124.247.841.704.420.281931.5917.914.96-154.03--12.75--
Jiangsu Jiangnan High Polymer Fiber534.12m27.93m3.84bn339.00137.291.86--7.200.01620.01620.30991.190.24321.6024.651,575,583.001.274.071.304.228.3817.485.2311.948.62--0.005127.27-34.09-14.05-17.23-14.29-49.85-9.71
Shaanxi Meibang Pharmaceuticl Grp Co Ltd871.63m29.78m3.88bn998.00130.163.38--4.450.22030.22036.458.490.4763.485.25873,380.501.636.562.169.3629.7134.353.4211.381.66--0.115618.4226.6811.42-35.96-13.5336.28--
Crown Advanced Material Co Ltd640.01m-126.92m3.89bn419.00--1.46--6.07-0.6839-0.68393.3213.190.21436.733.391,527,476.00-4.252.06-4.632.51-7.1912.64-19.834.269.88--0.0131222.10-38.13-1.79-180.95--2.81--
Shan Dong Lu Bei Chemical Co Ltd5.51bn67.24m3.96bn2.79k58.881.24--0.71880.12720.127210.426.060.60876.0921.501,972,024.001.764.374.279.298.2912.952.896.310.8411136.480.467715.8915.0615.73157.283.0123.08--
Shanghai Titan Scientific Co Ltd2.61bn14.35m3.96bn1.83k279.051.42--1.520.08640.086415.6616.980.53641.873.531,426,386.000.07272.920.10834.0521.6220.800.13553.891.271.050.341934.784.1120.31-82.23-29.5275.53--
Data as of Feb 13 2026. Currency figures normalised to Shanghai Titan Scientific Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

5.99%Per cent of shares held by top holders
HolderShares% Held
GF Fund Management Co., Ltd.as of 30 Jun 20252.38m1.45%
Harvest Fund Management Co., Ltd.as of 30 Jun 20252.26m1.38%
ICBC UBS Asset Management Co. Ltd.as of 30 Jun 20251.24m0.76%
China Fund Management Co., Ltd.as of 30 Jun 20251.21m0.74%
Rongtong Fund Management Co., Ltd.as of 30 Jun 20251.16m0.71%
Huashang Fund Management Co., Ltd.as of 30 Jun 2025519.44k0.32%
China Asset Management Co., Ltd.as of 30 Jun 2025333.23k0.20%
CCB Principal Asset Management Co., Ltd.as of 30 Jun 2025256.41k0.16%
Golden Eagle Asset Management Co., Ltd.as of 30 Jun 2025256.21k0.16%
E Fund Management Co., Ltd.as of 30 Jun 2025237.14k0.14%
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.